TNFSF10 and prostate neoplasm: In order to overcome this issue, we hypothesize that a Lf-bearing DAB dendrimer complexed to plasmid DNA encoding TNFα, TRAIL, and IL-12 would enhance the delivery of therapeutic DNA to prostate tumors and increase its therapeutic efficacy in vitro as well as in vivo.